Sophia Sundararajan is a Neurology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 97 publications with 2,990 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-3192Provider last certified this registry record 3 Dec 2020.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20253 payments
- PFIZER INC.Program year20253 payments
- UCB, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
66%Other antiepileptics20.8%Levetiracetam46%Topiramate41%Lacosamide14%Part D<11 patientsGabapentinoids13.2%Gabapentin86%Pregabalin14%Part D<11 patients+ 9 more classes in this area
Cardiovascular
15.8%Statin11%Atorvastatin Calcium81%Rosuvastatin Calcium19%Part D<11 patientsAngiotensin receptor blocker (ARB)1.7%Losartan Potassium100%Part D<11 patients+ 2 more classes in this area
Blood & clotting
11.1%P2Y12 inhibitor5.6%Clopidogrel100%Part D≥17 patientsFactor Xa inhibitor3.9%Eliquis100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2003–2026 per NIH RePORTER. The latest:
- Case Western Reserve University StrokeNet University Regional Coordinating Center
Case Western Reserve University
FY2026$429,468U24NS107270 - Case Western Reserve University StrokeNet University Regional Coordinating Center
Case Western Reserve University
FY2025$1U24NS107270 - Case Western Reserve University StrokeNet University Regional Coordinating Center
Case Western Reserve University
FY2024$429,468U24NS107270
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Sylvia Asa, MD, PhD
University Hospitals of Cleveland
Lloyd Greene, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
Ian Neeland, MD
University Hospitals of Cleveland
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”